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We compared three methods used microbial culturing for detection of ureaplasmas in endotra-
cheal aspirate from 500 prematurely born neonates with respiratory disturbances: BioMerieux 
test, PCR and microbial culturing. Ureaplasmas were detected in respiratory tracts of 79 (16%) 
newborns. Correlation of the results of culture with those obtained with the BioMerieux kit, cul-
ture with PCR and BioMerieux kit with PCR was 97%, 89% and 90%, respectively. Sensitivity 
and specificity of PCR in comparison with culture was 86% and 98%, respectively, and of the 
BioMerieux kit 96% and 98%. PCR can be recommended in rapid diagnostics of respiratory infec-
tions in newborns suffering from respiratory disorders. It allows the detection of ureaplasmas in 
case of parallel infections and identification of their species.
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Ureaplasmas are isolated from the lower gen-
ital tract of 60–80% of pregnant women. They are 
transmitted from mothers to neonates, either in utero 
or during passage through the infected birth canal. 
Vertical transmission is most frequent in infants of 
birth weight less than 1000 g. A consequence of ure-
aplasma infection could be respiratory insufficiency 
in newborns and other diseases (Gravett et al., 1986; 
Waites et al.,  1988; Lauterbach et al., 1995; Regan & 
Greenberg, 2001). Respiratory tract colonisation of 
premature infants has been consistently associated 
with pneumonia, bronchopulmonary dysplasia and 
chronic lung disease (Waites et al., 1989; Pacifico et 
al., 1997; Da Silva et al., 1997).
Culturing of ureaplasmas is difficult and time-
consuming. Special culture media and growth con-
ditions are necessary. Routine bacterial cultures are 
not sufficient to recover Ureaplasma species. Isolation 
by culture is considered the gold standard for detec-
tion of ureaplasmas. Unfortunately, it is expensive, 
requiring special handling and rich media. Further-
more, it may take 2 to 5 days to obtain a result. In 
newborns, an additional problem is the necessity of 
antibiotic administration before the diagnostic proce-
dures are started. Antibiotics inhibit the growth of 
ureaplasmas, thus limiting the reliability of the cul-
ture method.
 A search for new methods is ongoing. Such 
methods should be of a comparable sensitivity and 
specificity as the classic culture method but at the 
same time, they should have the advantage of being 
easy and fast. Therefore molecular techniques are 
constantly becoming more important in diagnostics. 
Rapid detection is needed to diagnose infection in 
newborns. Currently, the polymerase chain reaction 
(PCR) appears to be the most promising method 
for detecting these organisms. Recently PCR based 
methods have been used successfully to distinguish 
two Ureaplasma species. Sequences of the 16S rRNA 
gene and the 16S rRNA–23S rRNA intergenic spacer 
regions, genus for urease subunits and the 5’ ends of 
the multiple-banded antigen (MBA) genes are used 
as targets in PCR-based assays (Kong et al., 2000). At 
present there are no commercially available molecu-
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lar tests, which could be used in the diagnostics of 
ureaplasma infections.
The purpose of our study was to compare 
three diagnostic methods of ureaplasma identifica-
tion in newborns with respiratory disorders: culture 
in PPLO medium, a commercial test and PCR with 
primers, which should differentiate between two 
species of ureaplasmas.
MATERIALS AND METHODS
Patients. Materials for this study were ob-
tained from 500 newborns with respiratory distur-
bances hospitalised in a clinic supervised by the 
Chair of Neonatology, Jagiellonian University Medi-
cal College in Cracow (Poland).
Detection of ureaplasmas. Endotracheal aspi-
rates were collected from each infant and placed in 
BioMerieux transport media. Next, they were sub-
cultured in liquid and solid PPLO media according 
to the procedure described by Shepard (1986) and 
parallelly in Mycoplasma IST 2 kit BioMerieux me-
dium (R2). Liquid media and BM test strips were in-
cubated for 72 h at 37oC, solid media for 5–7 days. 
The growth of microorganims on liquid PPLO media 
was observed as a change of colour of the medium 
(hydrolysis of urea with the release of ammonia, sig-
nalled by a colour change of a pH indicator), while 
on solid media it was the presence of characteristic 
brownish colonies of ureaplasmas (magnification 
125×). Similarly to liquid PPLO, Mycoplasma IST 2 
test is based on a colour change reaction, owing to 
alkalization of the medium in the presence of urea-
plasmas. A positive IST 2 test result was observed 
when the colour of microwells of the diagnostic strip 
changed from yellow to red.
Isolation of DNA of ureaplasmas. Crude 
ureaplasma DNA was isolated from R2 medium 
after 18–24 h of incubation by means of centrifuga-
tion (14 000 × g, 20 min, 4oC) and denaturation of the 
sediment in 100 µl of sterile, distilled water at 95oC. 
PCR with species-specific primers. PCR 
was applied to test for genome specific regions of 
two ureaplasma species (biovars) occurring in man: 
U. parvum and U. urealyticum. Primers for U. par-
vum were UPS2c, UPA2c (420 bp), for U. urealyti-
cum there were UUS2c, UUA2c (420 bp) (Kong et 
al., 2000). Forty thermal cycles were performed, 
each consisting of: 95oC 5 min, 92oC 1.5 min, 55oC 
2 min, 72oC 1.5 min, 72oC 8 min.  The PCR solution 
(25 µl) contained: 10 mM Tris/HCl, pH 8.3, 50 mM 
KCl, 1.5 mM MgCl2, 0.2 mM dNTP, 10 pmol prim-
ers, 0.5 U Taq polymerase, 5 µl target sample. DNA 
from reference strains was used as a positive con-
trol for identification of biovars of ureaplasmas: se-
rotype IV ATCC 27816 (U. urealyticum) and serotype 
III ATCC 27815 (U. parvum). Negative control was 
distilled water. Amplified products were visualized 
under ultraviolet light after electrophoresis through 
a 2% agarose gel containing 3 µl ethidium bromide.
RESULTS
Ureaplasmas were detected in 79 (16%) in-
fants. Positive results of culture, the Mycoplasma 
IST 2 test and PCR were obtained for 68, 77 and 75 
materials, respectively. In 40 cases, culturing was im-
possible because of accompanying bacterial flora. In 
these cases, PCR was relevant. In four samples posi-
tive results of BioMerieux kit were not confirmed 
by PCR. Positive result of one sample assessed by 
PCR did not correspond with the result of culture. 
Correlation, sensitivity and specificity of PCR and 
BioMerieux kit compared with cultivation on PPLO 
media are shown in Table 1.
DISCUSSION
In this study, we evaluated and compared 
the usefulness of various diagnostic methods of 
ureaplasma infections: PCR amplification, a com-
mercial BioMerieux test and culturing on solid and 
in liquid media. We applied species-specific primer 
sets: UPS2, UPA2 (U. parvum) and UUS2c, UUA2c 
(U. urealyticum) targeting the ureA-ureB and ureB-
ureC gene spacer regions, respectively. UPS2-UPA2 
primers were specific for all amplified serovars of 
U. parvum, UUS2-UUA2 were specific for all sero-
vars of U. urealyticum (Kong et al., 2000). 
It was recently reported that the sensitivity 
and specificity of cultivation techniques is compa-
rable to the sensitivity and specificity  of molecular 
methods commercial tests currently applied (Blan-
hard et al., 1993; Abele-Horn et al., 1996; Clegg et 
al., 1997; Fernandez et al., 1998). Although cultiva-
tion is regarded as the gold standard in identifying 
mycoplasma and ureaplasma infections, it only ena-
bles the detection of living cells which multiply in 
artificial media. When live microorganisms are not 
present in the specimen or, owing to various rea-
sons, they are not able to survive outside the host, 
the results obtained by this method may be falsely 
Table 1. Correlation, sensitivity and specificity of PCR 
and BioMerieux kit compared with cultivation on PPLO 
media as the gold standard.
PCR/C PCR /BM BM/C
Correlation 97% 98% 97%
Specificity 98% 99% 97%
Sensitivity 92% 91% 97%
C, culture; BM, BioMerieux kit (Mycoplasma IST 2)
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negative. This possibility was for example addressed 
by Teng et al. (1994). 
It may also be impossible to detect ureaplas-
mas by culturing method when some other rapidly 
growing bacteria are present in the specimen. In our 
study, in as many as 40 (8%) such cases the PCR 
method was decisive.
The specificity and sensitivity of ureaplasma 
detection by culturing in PPLO broth were only 
slightly worse (both 97%) than those of the com-
mercial test. Its specificity compared with the PCR 
method was also satisfactory (98%), but the sensitiv-
ity was found to be much lower (92%). Our results 
are consistent with other authors’ observations that 
the cultivation method is less sensitive (Teng et al., 
1994; Luki et al., 1998). This relatively low frequency 
of ureaplasma detection by means of culturing may 
be attributed in part to the difficulties in growing 
and isolation of these microorganisms. 
The results of PCR amplification are less 
prone to being influenced by the method of speci-
men collection and handling. PCR analysis is also 
much quicker; results can be obtained in 1–2 days, 
whereas it takes 5–7 days in the case of cultivation 
and 3–5 days when the commercial test is applied. 
In four cases the positive result of Mycoplasma IST 
2 test was not confirmed by PCR. The rapid test re-
sults (the BioMerieux test belongs to this category) 
may sometimes be falsely positive (Rastawicki et al., 
2004). Ureaplasmas produce ureases that degrade 
urea to ammonia and thus, shift the pH of the me-
dium to more alkaline values resulting in a change 
of medium colour and such change is taken as in-
dicative of the presence of ureaplasmas. However, 
one must remember that ureaplasmas are not the 
only microorganisms capable of hydrolyzing urea 
with urease. In the presence of other bacteria (e.g. 
Proteus, Klebsiella) we may also observe alkaliza-
tion of the culture medium and the result may then 
be misinterpreted as positive. In four cases in our 
study, the positive result of the commercial test was 
not confirmed by the molecular method owing to 
the fact that the colour reaction was unspecific. The 
possibility of such misinterpretation can be limited 
by the use of commercial test strips along with solid 
media and tracking the growth of ureaplasmas and 
other flora forming bacterial colonies in the exam-
ined specimen. The necessity of applying both tests 
increases cost and is time-consuming. The molecu-
lar method also is advantageous because it enables 
rapid species identification, which in the near future 
may broaden our knowledge about the pathogenic-
ity of both ureaplasma species. It also allows the 
detection of ureaplasmas in case of accompanying 
infections, enables identification their species and is 
the quickest of the three diagnostic method used in 
our study.
CONCLUSION
PCR, as a highly sensitive and specific meth-
ods, can be recommended in rapid diagnostics for 
respiratory infections in newborns suffering from 
respiratory disorders. 
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